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Major histocompatibility complex (MHC) restriction
is the cardinal feature of T cell antigen recognition
and is thought to be intrinsic to ab T cell receptor
(TCR) structure because of germline-encoded resi-
dues that imposeMHC specificity. Here, we analyzed
abTCRs from T cells that had not undergone MHC-
specific thymic selection. Instead of recognizing
peptide-MHC complexes, the two abTCRs studied
here resembled antibodies in recognizing glycosyla-
tion-dependent conformational epitopes on a native
self-protein, CD155, and they did so with high affinity
independently ofMHCmolecules. Ligand recognition
was via the abTCR combining site and involved the
identical germline-encoded residues that have been
thought to uniquely impose MHC specificity, demon-
strating that these residues donot only promoteMHC
binding. This study demonstrates that, withoutMHC-
specific thymic selection,abTCRs can resemble anti-
bodies in recognizing conformational epitopes on
MHC-independent ligands.
INTRODUCTION
The adaptive immune system is composed of T and B lympho-
cytes bearing antigen receptors generated by gene recombina-
tion to recognize a huge diversity of different antigens. Although
generated by the same recombination machinery, antigen re-
ceptors on T and B cells recognize fundamentally different kinds
of antigenic ligands. Antigen receptors on B cells recognize
conformational epitopes on native proteins, whereas antigen
receptors on mature ab T cells (abTCRs) recognize only linear
peptides of antigenic proteins bound to products of the major
histocompatibility complex (MHC) (Davis and Bjorkman, 1988).
The unique recognition characteristic of mature T cells is referredto as MHC restriction because they are restricted to recognizing
only peptides of antigenic proteins bound to MHC glycoproteins
as antigenic peptide-MHC (pMHC) complexes. MHC restriction
focuses T cell recognition on cell-bound MHC molecules that
display peptides derived from proteins either synthesized within
the cell or pinocytosed from extracellular fluids. MHC-restricted
antigen recognition is the cardinal feature of abTCR recognition
and is central to ab T cell function, but its basis is not known.
One perspective proposes that MHC restriction is germline
encoded and intrinsic to abTCR structure (Feng et al., 2007;
Huseby et al., 2005; Merkenschlager et al., 1997; Zerrahn
et al., 1997). The germline concept is supported by structural
analyses of abTCRs which reveal that abTCR binding to pMHC
complexes not only involves amino acid residues encoded in
the highly variable complementary determining region (CDR) 3
that directly contact antigenic peptides in the MHC groove,
but also involves evolutionarily conserved amino acid residues
encoded in the invariant CDR2 region that directly contact
MHC a helices (Garcia et al., 2009; Marrack et al., 2008; Rudolph
et al., 2006). Based on these structural analyses, it has been
proposed that germline-encoded amino acid residues in the
invariant CDR2 region specifically promote MHC binding and
account for the preferential binding of abTCRs to pMHC com-
plexes (Garcia et al., 2009; Marrack et al., 2008). Notably, the
germline basis of MHC restriction is not contradicted by reports
of rare abTCRs cloned from conventional T cell populations that
bind ligands independently of MHC molecules (Barnd et al.,
1989; Hanada et al., 2011; Rao et al., 1984; Siliciano et al.,
1985) because their MHC-independent ligand is bound with
such low apparent affinity that it is likely not to be their TCR’s
primary recognition specificity (Garcia et al., 2009).
An alternative to the germline concept is that MHC restriction
is imposed by thymic selection (Collins and Riddle, 2008; Van
Laethem et al., 2007). The thymic selection concept proposes
that abTCRs specific for MHC-independent ligands exist and
are expressed on preselection thymocytes but fail thymic selec-
tion and so are excluded from themature ab T cell repertoire (Van
Laethem et al., 2007). A key presumption of this perspective
is that thymic selection distinguishes MHC-specific fromImmunity 36, 79–91, January 27, 2012 ª2012 Elsevier Inc. 79
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abTCRs with Unique Ligand SpecificitiesMHC-independent abTCRs, but a potential mechanism for
distinguishing MHC-specific from MHC-independent ligand
engagements was only recently proposed (Van Laethem et al.,
2007). Extending observations in mature T cells (Haughn et al.,
1992) to preselection thymocytes, we proposed that Lck, the
kinase necessary for most TCR signaling, is sequestered away
from abTCRs on preselection thymocytes by CD4 and CD8 cor-
eceptor proteins that bind to MHCmolecules, with the result that
immature thymocytes can only be signaled to undergo selection
by abTCRs that access Lck by coengaging pMHC complexes
together with CD4 or CD8 coreceptors (Van Laethem et al.,
2007). However, if preselection thymocytes were deficient in
both CD4 and CD8 coreceptor proteins, Lck would be available
to all abTCRs, whichwould signal thymic selection upon engage-
ment of any intrathymic ligand. Thus, CD4 and CD8 coreceptor
proteins imposeMHC specificity on thymic selection and impose
MHC restriction on themature abTCR repertoire. In this perspec-
tive, every abTCR that has been analyzed to date possesses
structural features that promote binding to MHC molecules
because each abTCR had been prescreened for MHC specificity
in the thymus (Marrack et al., 2008; Rudolph et al., 2006).
We now characterize abTCRs obtained from mature T cells
that had not undergone MHC-specific selection in the thymus.
We analyzed two autoreactive abTCRs cloned from T cells in
the lymphoid periphery of mice deficient in both MHC and core-
ceptor proteins (so-called Quad-deficient mice) (Van Laethem
et al., 2007). Remarkably, instead of pMHC complexes, these
two abTCRs recognized conformational epitopes on the self-
protein CD155 and did so with an apparent affinity that was
substantially higher than the affinity with which conventional
abTCRs bind to cognate pMHC complexes. Binding to their
MHC-independent ligand depended on specific CDR3a se-
quences in the TCR combining site and also depended on the
identical CDR2b amino acid residues (Y46, Y48, E54) that have
been proposed to confer germline-encoded MHC specificity
(Scott-Browne et al., 2009). Thus, our study demonstrates that,
without MHC-specific thymic selection, abTCRs on postthymic
T cells can resemble antibodies in recognizing conformational
epitopes on MHC-independent ligands.
RESULTS
Specificity of abTCRs that Did Not Undergo
MHC-Specific Thymic Selection
To obtain ab T cells that had not been screened in the thymus for
MHC specificity, we utilized mice deficient in both MHC and cor-
eceptor proteins (B2m/H-2-Ab1/Cd4/Cd8a/mice) that
we refer to as Quad-deficient mice. Quad-deficient mice contain
peripheral ab T cells whose numbers are further increased by the
antiapoptic Bcl-2 transgene (Bcl-2Tg) that prevents strongly
signaled Quad-deficient thymocytes from undergoing clonal
deletion (Van Laethem et al., 2007). Because MHC complexes
are not expressed in Quad-deficient.Bcl2 mice, their T cells
express abTCRs that have not been screened for peptide-
MHC specificity and so might display unique recognition speci-
ficities. Indeed, Quad-deficient.Bcl2 ab T cells recognized and
responded against cell surface ligands on MHC-deficient stimu-
lator cells, whereas conventional MHC-selected ab T cells from
B6 or B10.A mice did not (Figure 1A).80 Immunity 36, 79–91, January 27, 2012 ª2012 Elsevier Inc.To study the ligand specificities of MHC-unselected abTCRs,
we generated multiple T hybridoma cell lines from Quad-
deficient.Bcl2 T cells that reacted against MHC-deficient stimu-
lators. We selected two T hybridomas, A11 and B12, to be
studied in detail (Figure 1B) and sequenced their TCR chains
(Figure 1C; Figure S1 available online). A11 T hybridoma cells
expressed one TCRa and one TCRb chain to form a TCR that
was Va8Vb8.1 and was designated A11. B12 T hybridoma cells
expressed two TCRa chains that were both Va4 and one TCRb
chain that was Vb3 to form two different Va4Vb3 TCRs, referred
to as B12A and B12F (Figures 1B and S1). The TCRa chains were
from different Va4 subfamilies (TRAV6D-6*02 and TRAV6-6*01)
and differed mainly in their Ja regions (J37*01 versus J42*01).
The Va4Vb3 TCR containing the TRAV6D-6*02 J37*01 TCRa
chain was designated B12A, and the Va4Vb3 TCR that uses
the TRAV6-6*01 J42*01 TCRa chain was designated B12F.
To determine the ligand specificities of A11, B12A, and B12F
TCRs, we retrovirally transduced each TCR into the TCR-nega-
tive 4G4 T cell line, which is also coreceptor negative (Hong
et al., 1992). Untransduced 4G4 cells lacked TCRs and so could
not be stimulated by anti-TCR (Figure 1D). However, 4G4 cells
transduced with A11, B12A, and B12F TCRs did respond to
anti-TCR stimulation, indicating that they expressed functional
abTCRs (Figure 1D). Importantly, 4G4 cells expressing A11 and
B12A TCRs also responded against MHC-deficient and MHC-
sufficient stimulators, whereas 4G4 cells expressing B12F
TCRs did not (Figure 1D). Thus, A11 and B12A TCRs recognized
MHC-independent ligands expressed on MHC-deficient stimu-
lator cells but B12F TCR displayed no observable ligand speci-
ficity. We then retrovirally transduced A11, B12A, and B12F
TCRs into human peripheral blood lymphocytes (hPBLs) to
assess ligand recognition without contribution from species-
specific adhesion molecules (Figure 1E). The murine TCRs
were functional in hPBLs as shown by the fact that they signaled
human interferon-g (hIFN-g) secretion in response to antimurine
TCR.More importantly, A11 andB12A TCRs on hPBLs conferred
reactivity to MHC-deficient murine stimulators (Figure 1E), dem-
onstrating that these TCRs recognized murine ligands with suffi-
ciently high affinity to signal responses without contribution from
species-specific adhesion molecules.
CD155 Is a Self-Protein Recognized by A11 and B12A
TCR Independently of MHC
To identify the stimulatory ligand(s) recognized by A11 and B12A
TCRs, we performed limiting dilution cDNA expression cloning.
We generated a cDNA library from the murine L1210 cell line
that potently stimulated both A11 and B12A TCRs (Figure S2)
and introduced the L1210 cDNA library into the human 293T
cell line that was nonstimulatory for both TCRs (Figure S2). We
ultimately identified three cDNA clones, each of which encoded
stimulatory ligand(s) for both A11 and B12A TCRs. To our
surprise, all three stimulatory cDNA clones encoded the same
protein, namely murine CD155 (mCD155), which is the murine
analog of the human poliovirus receptor and is expressed in
varying amounts on hematopoietic and nonhematopoietic cells
(Chade´neau et al., 1996a, 1996b; Maier et al., 2007).
To confirm that mCD155 was indeed the ligand recognized by
both A11 and B12A TCRs, we transfected bona fide mCD155
cDNA into 293T cells and used the transfected cells to stimulate
Figure 1. abTCR from Quad-Deficient Mice Recognize Ligands Independently of MHC Molecules
(A) Reactivity of ab T cells from B6 and Quad-deficient mice. Proliferation of CFSE-labeled LN ab T cells (1 3 105) was measured after 4 days of culture with
23 105 stimulator cells (T cell-depleted, LPS-stimulated, and irradiated splenocytes). Stimulation with soluble anti-TCRb (1 mg/ml) in the presence of FcR+ cells
from MHC-deficient (MHC-KO) mice served as a positive control. Data are representative of six independent experiments.
(B) Specificity of A11 and B12 T hybridomas generated from Quad-deficient.Bcl2 ab T cells. T hybridomas (1 3 105) were cultured with stimulators (2 3 105) or
plate-bound anti-TCRb (5 mg/ml) for 16 hr and assayed for IL-2 production by proliferation of the IL-2-dependent cell line CTLL. Each data point represents the
mean (±SEM) of triplicate cultures. Data are representative of five independent experiments.
(C) Characterization of abTCRs from A11 and B12 T hybridomas. The A11 T hybridoma expressed a TCR Va8 chain and a TCR Vb8.1 chain and we refer to this
TCR pair as ‘‘A11.’’ The B12 T hybridoma contained a TCR Vb3 chain and two TCR Va4 chains that were from different subfamilies (TRAV6D-6*02 and TRAV6-
6*01) and contained different Ja regions (J37*01 and J42*01). The ‘‘B12A’’ TCR consists of the TCR Vb3 chain paired to the TRAV6D-6*02 J37*01 chain, and the
‘‘B12F’’ TCR consists of the TCR Vb3 chain paired to the TRAV6-6*01 J42*01 chain.
(D) Reactivity of untransduced or TCR-transduced 4G4 cells (43 104) against stimulators (23 105) or plate-bound anti-TCRb (5 mg/ml) after 16 hr stimulation as
determined by ELISA quantification of IL-2 secretion. Data are representative of five independent experiments.
(E) Reactivity of hPBL transduced with murine TCR (2 3 105) against stimulators (5 3 105) or plate-bound anti-TCRb (murine, 5 mg/ml) as determined by ELISA
quantification of hIFN-g secretion. Each data point represents the mean (±SEM) of triplicate culture. Data are representative of two independent experiments.
See also Figure S1.
Immunity
abTCRs with Unique Ligand SpecificitiesTCR-transduced 4G4 cells. 4G4-transduced cells expressing
A11 and B12A TCR responded against 293T cells transfected
with mCD155 cDNA but did not respond against 293T cells
transfected with human CD155 (hCD155) cDNA, documenting
that mCD155 was the stimulatory ligand for both A11 and
B12A TCRs (Figure 2A). In addition, A11 and B12A TCRs, which
signaled 4G4 and hPBL to respond against wild-type murine
stimulator cells, failed to signal responses against CD155-deficient stimulator cells from Cd155/ (CD155-deficient)
mice (Maier et al., 2007), confirming that both TCRs recognized
and reacted against mCD155 proteins on murine stimulator cells
(Figures 2B and 2C).
Before concluding that mCD155 was the MHC-independent
ligand recognized by A11 and B12A TCRs, we documented
that mCD155 was the ligand specifically recognized by A11
and B12A TCRs on MHC-deficient stimulator cells. Indeed,Immunity 36, 79–91, January 27, 2012 ª2012 Elsevier Inc. 81
Figure 2. Murine CD155 Is the Ligand Recognized by A11 and B12A TCRs
(A) IL-2 production by TCR-transduced 4G4 cells (4 3 104) after 16 hr stimulation with 293T cells transfected with cDNA encoding either hCD155 or mCD155.
(B) TCR-transduced 4G4 cells (4 3 104) do not respond against CD155-deficient stimulators (5 3 105).
(C) TCR-transduced hPBL (2 3 105) do not respond against CD155-deficient stimulators.
(D) TCR-transduced 4G4 cells (4 3 104) do not respond against MHC- and CD155-deficient stimulators (5 3 105).
(E) Anti-mCD155 (10 mg/ml) blocks stimulation of TCR-transduced 4G4 cells (4 3 104) by MHC-deficient (MHC-KO) stimulators (5 3 105).
(F) Anti-mCD155 (10 mg/ml) blocks stimulation of TCR-transduced 4G4 cells (4 3 104) by 293T cells transfected with cDNA encoding mCD155.
Each data point represents the mean (±SEM) of triplicate culture. Data are representative of five (A), three (B, D–F), or two (C) experiments. See also Figure S2.
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abTCRs with Unique Ligand SpecificitiesA11 and B12A TCRs responded against MHC-deficient stimu-
lator cells but did not respond against MHC-deficient stimulator
cells that were additionally CD155 deficient, documenting that
mCD155 was the stimulatory ligand on MHC-deficient cells
(Figure 2D).82 Immunity 36, 79–91, January 27, 2012 ª2012 Elsevier Inc.TCR Recognition of Native mCD155 Proteins in the
Absence of Antigen Processing
Ligand recognition by conventional abTCRs requires antigen
processing, which involves degradation of antigenic proteins
into peptide fragments that are subsequently loaded onto
Figure 3. A11 and B12A TCRs Directly Recognize
Recombinant mCD155 Protein Immobilized on
Plastic
(A) Responses of TCR-transduced 4G4 cells (4 3 104)
to immobilized (10 mg/ml) or soluble (10 mg/ml) CD155
protein.
(B) Responses of TCR-transduced hPBL to immobilized
CD155 protein (10 mg/ml).
Each data point represents the mean (±SEM) of triplicate
culture. Data are representative of four (A) or two (B)
independent experiments.
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abTCRs with Unique Ligand SpecificitiesMHC molecules and expressed on the cell surface. As a conse-
quence, ligand recognition by conventional abTCRs cannot be
blocked by antibodies directed against native antigenic proteins
(Schwartz et al., 1976). However, because antigen recognition
by A11 and B12A TCRs is MHC independent, we considered
that their ligand recognition might be susceptible to blockade
by antibodies directed against the native antigenic protein. In
fact we observed that A11 and B12A responses were blocked
by anti-mCD155 (Figures 2E and 2F).
Blockade of CD155-specific responses by anti-mCD155 sug-
gested that ligand recognition by A11 and B12A TCRs did
not require antigen processing. Consequently, we wondered
whether these TCRs could respond to recombinant mCD155
proteins that had not undergone antigen processing and in the
absence of antigen-presenting cells (APCs). We observed that
TCR-transduced 4G4 and hPBL expressing A11 and B12A
TCRs both responded to platebound recombinant mCD155
protein (Figures 3A and 3B). These responses were TCR specific
as shown by the fact that transduced cells expressing A11 and
B12A TCRs responded but those expressing B12F TCRs didImmunity 36not, and these responses were antigen specific
as shown by the fact that they were specific for
immobilized mCD155 but not immobilized
hCD155 (Figures 3A and 3B).
We conclude that, unlike conventional
abTCRs, A11 and B12A TCRs recognize native
mCD155 proteins and do so without antigen
processing.
Frequency of T Hybridomas with CD155
Specificity
Although A11 and B12 T hybridomas were
generated from the same Quad-deficient.Bcl2
T cell population, we were surprised that their
abTCRs recognized the same protein ligand,
i.e., mCD155, so we decided to assess whether
CD155 specificity was frequent among newly
generated Quad-deficient T hybridomas. We
stimulated Quad-deficient.Bcl2 primary T cells
with immobilized anti-TCR+anti-CD28 and
fused them with BW5147 thymoma cells
to generate a large panel of Quad-deficient
T hybridomas. Remarkably, we found that
40% of newly generated TCR+ Quad-deficient
T hybridomas displayed CD155 specificity,
which might either reflect preferential survivalof T hybridomas bearing CD155-specific TCRs or infer that
CD155 was a predominant ligand for MHC-independent Quad-
deficient T cells. Contrary to this latter possibility, polyclonal
Quad-deficient primary T cells proliferated as vigorously against
CD155-deficient as against CD155-sufficient stimulators (Fig-
ures 4A and S3). Consequently, we think that Quad-deficient T
hybridomas display a markedly skewed sample of the MHC-
independent ligand specificities present among Quad-deficient
primary T cells.
Recognition of Different Conformational Epitopes
on mCD155
To determine whether A11 and B12A TCRs, both of which were
CD155 specific, actually recognized different antigenic epitopes
on CD155, we stimulated A11 and B12A TCRs with 293T cells
that had been transfected with cDNA encoding murine-human
CD155 chimeric proteins in which each of the three mCD155
domains (D1, D2, and D3) was replaced by its hCD155 counter-
part (Figure 4B). We found that stimulation of B12A TCR
required the murine D1 domain because they did not respond, 79–91, January 27, 2012 ª2012 Elsevier Inc. 83
Figure 4. Ligand Specificity of MHC-Independent
abTCRs
(A) CD155 protein is not a unique ligand for polyclonal ab
T cells. Proliferative responses were measured by CFSE
dye dilution of primary ab T cells from Quad-deficient.Bcl2
(Quad-KO.Bcl2) mice against various stimulators.
(B) CD155 epitopes recognized by MHC-independent
TCRs. Schematic representation of chimeric mouse-
human CD155 molecules are displayed (left). IL-2 re-
sponse of TCR-transduced 4G4 cells (4 3 104) stimulated
with 293T cells transfected with cDNA encoding various
CD155 chimeric constructs (right).
(C) IL-2 response of TCR-transduced 4G4 cells (1 3 105)
stimulated with either native or heat-denatured recombi-
nant mCD155 protein.
Each data point represents the mean (±SEM) of triplicate
culture. Data are representative of two (A, B) or three (C)
independent experiments. See also Figure S3.
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abTCRs with Unique Ligand Specificitiesagainst mCD155 chimeric proteins containing the human D1
domain (Figure 4B), and that stimulation of A11 TCR required
both murine D1 and D2 domains because they did not respond
against mCD155 chimeric proteins containing either human D1
or D2 domains (Figure 4B). Thus, A11 and B12A TCRs recog-
nize different mCD155 epitopes, with B12A recognizing an
epitope confined to the D1 domain of mCD155 and A11 recog-
nizing a complex epitope composed of both D1 and D2
domains.
Because conventional abTCRs do not recognize conforma-
tional epitopes on native antigenic proteins, denaturation of
the antigenic protein does not affect their recognition by con-
ventional abTCRs. In marked contrast, we found that heat dena-
turation of recombinant mCD155 proteins abolished A11’s
recognition of its complex D1-D2 epitope and reduced B12A’s
recognition of its D1 epitope (Figure 4C). These results demon-84 Immunity 36, 79–91, January 27, 2012 ª2012 Elsevier Inc.strate that A11 and, to a lesser extent, B12A re-
cognize conformational epitopes on mCD155
proteins.
TCR Recognition of CD155 Depends
on Glycosylation
Because conventional abTCRs recognize linear
peptides of antigenic proteins presented by
MHC, glycosylation of the antigenic protein
from which the peptides are derived does
not usually enhance T cell immunogenicity. In
contrast, A11 and B12A TCRs recognized con-
formational antigenic epitopes, and conforma-
tional epitopes are often affected by glyco-
sylation. Consequently, we compared antibody
recognition and TCR responses to plate-bound
recombinant CD155 proteins that were either
glycosylated or nonglycosylated (Figure 5).
Polyclonal CD155-specific antibodies did not
distinguish glycosylated and nonglycosylated
CD155 proteins because they recognized both
(Figure 5, bottom), but two different CD155-
specific monoclonal antibodies detected only
glycosylated CD155 and failed to detect nongly-cosylated CD155 (Figure 5, middle), indicating that the confor-
mational epitopes recognized by the mAbs were dependent on
CD155 glycosylation. Interestingly, CD155-specific responses
by A11 and B12A TCRs resembled the two mAbs in discrimi-
nating between glycosylated and nonglycosylated CD155 pro-
teins. Indeed, A11 and B12A TCRs both responded to glycosy-
lated CD155 but failed to respond to nonglycosylated CD155
proteins (Figure 5, top). Thus, antigen recognition by A11 and
B12A TCRs resembled monoclonal antibodies in being depen-
dent on glycosylation and differed fundamentally from that by
conventionally MHC-selected abTCRs.
Role of CDR3a TCR Residues in Ligand Recognition
To better understand the basis for abTCR recognition of
mCD155, we considered the possibility that A11 and B12A
TCRs might bind to mCD155 outside of their antigen combining
Figure 5. TCR Recognition of CD155 Depends on
Glycosylation
IL-2 response of TCR-transduced 4G4 cells (1 3 105)
stimulated with either glycosylated or nonglycosylated
recombinant CD155 (10 mg/ml) in medium (top), in the
presence of 10 mg/ml monoclonal anti-CD155 (clones
TX56 and 4.24.1) (middle), or in the presence of 10 mg/ml
polyclonal anti-CD155 (bottom). Each data point repre-
sents the mean (±SEM) of triplicate culture. Data are
representative of two experiments.
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abTCRs with Unique Ligand Specificitiessites, in a manner resembling superantigen binding to TCRb
chains (Li et al., 1999). Consequently, we performed mix-and-
match experiments in which we transduced 4G4 cells with mis-
matched a and b TCR chains from A11 and B12A. Mismatched
abTCR chains were functionally expressed on the 4G4 cell
surface as indicated by the fact that they signaled interleukin-2
(IL-2) secretion in response to anti-TCR stimulation (Figure 6A).
However, mismatched abTCR chains failed to respond to
MHC-deficient stimulators, indicating that correctly matched
abTCR pairs were required for mCD155 recognition.
Next, we examined whether the CDR3 TCR region, a major
component of the TCR combining site, was important for
mCD155 recognition. To pursue this possibility, we made use
of the fact that B12A andB12F TCRs differed dramatically in their
recognition of mCD155 but were structurally similar to one
another, with the major difference being Ja-encoded CDR3a
sequences (Figures 1B and S1). Consequently, we swapped
CDR3a sequences (identified in Figure S1) between B12A and
B12F TCRa chains and assessed responses to immobilized
recombinant mCD155 (Figure 6B). Impressively, replacingImmunity 36CDR3a sequences in B12F with those from
B12A (designated F-CDR3-A) resulted in acqui-
sition of mCD155 responsiveness (Figure 6B),
and replacing CDR3a sequences in B12A with
those from B12F (designated A-CDR3-F) re-
sulted in loss of mCD155 responsiveness (Fig-
ure 6B). Because both gain and loss of function
were observed in these CDR3a swaps, we con-
clude that MHC-independent recognition of
mCD155 by B12A TCR critically depends on
CDR3a TCR sequences and so is mediated by
the TCR combining site.
Role of Germline-Encoded CDR2b
Residues in Ligand Recognition
Structural analyses of conventional abTCRs
with peptide-MHC complexes have identified
germline-encoded CDR2 TCR residues that
contact MHC and promote MHC-specific
thymic selection (Scott-Browne et al., 2009). It
has been argued that such germline-encoded
CDR2 residues provide a simple and compelling
demonstration that MHC specificity is intrinsic
to the germline-encoded structure of abTCRs.
However, the presumption underlying this argu-
ment is that germline-encoded CDR2 residues
promote TCR binding only to peptide-MHCcomplexes, a presumption that could not previously be tested.
We could now directly test this presumption because A11
TCRb chains contain the canonical Vb8.1 CDR2b residues
(Y46, Y48, E54) that have been identified as MHC contact points
(Marrack et al., 2008; Scott-Browne et al., 2009). To determine
whether these CDR2b residues affected MHC-independent
TCR recognition of mCD155, we mutated to alanine each of
the three canonical residues (Y46A, Y48A, E54A) and retrovirally
transduced mutant A11 TCRb and wild-type TCRa chains into
4G4 cells (Figure 6C). All three mutant A11 TCRs were function-
ally expressed in 4G4 cells as they responded to anti-TCR stim-
ulation, but they differed in their recognition of recombinant
mCD155 protein (Figure 6C). Strikingly, mutation of Y48 in
the TCRb chain completely abrogated A11 responsiveness to
mCD155 protein, and TCRb mutations of Y46 and E54 reduced
A11 responsiveness (Figure 6C). These findings unexpectedly
reveal that germline-encoded CDR2b residues are critically
important for MHC-independent ligand recognition of CD155
conformational epitopes even though the structure of CD155 is
distinct from that of MHC (He et al., 2000; Zhang et al., 2008)., 79–91, January 27, 2012 ª2012 Elsevier Inc. 85
Figure 6. Ligand Recognition by A11 and B12A TCR
(A) Ligand recognition by A11 and B12A TCRs requires specific ab pairing. IL-2 responses of 4G4 cells (4 3 104) transduced with the indicated TCR chains.
(B) Importance of CDR3a-encoded TCR sequences for CD155 recognition. CDR3a sequences were exchanged between B12A and B12F to generate chimeric
F-CDR3-A and A-CDR3-F TCRa chains. F-CDR3-A designates B12F TCRa chains with B12A CDR3a sequences, and A-CDR3-F designates B12A TCRa chains
with B12F CDR3a sequences. The indicated TCRa chains were transduced together with B12 TCRb chains into 4G4 cells, and the TCR-transduced 4G4 cells
(1 3 105) were stimulated with mCD155 (10 mg/ml).
(C) Role of CDR2b-encoded Y46, Y48, E54 TCR residues in mCD155 recognition. Y46, Y48, E54 amino acid residues in the TCR Vb8.1 chain of the A11 TCRwere
each mutated to alanine, transduced into 4G4 cells along with the A11 TCRa chain, and stimulated with mCD155 protein (10 mg/ml).
Each data point represents the mean (±SEM) of triplicate culture. Data are representative of two (A) or three (B, C) experiments.
Immunity
abTCRs with Unique Ligand SpecificitiesA11 and B12A TCRs Are Not Alloreactive and Have No
Apparent Peptide-MHC Specificity
We then wondered whether either A11 or B12A TCR could
recognize syngeneic or allogeneic peptide-MHC complexes in
addition to mCD155. To assess this possibility, 4G4 cells ex-
pressing A11 and B12A TCRwere stimulated by cells expressing
a variety of MHC and background genes, and responses were86 Immunity 36, 79–91, January 27, 2012 ª2012 Elsevier Inc.assessed in the presence and absence of blocking mCD155
mAb (Figure 7A). Notably, anti-CD155 did not interfere with the
responses of conventional MHC-selected T cells from B6 mice
against allogeneic BALB/c (H-2d), A/J (H-2a), or CBA (H-2k) stim-
ulator cells (Figure 7A). However, anti-CD155 abrogated re-
sponses by A11 and B12A TCRs to the entire panel of stimulator
cells, regardless of theirMHCandbackground genes (Figure 7A).
Figure 7. A11 and B12A TCR Specificities
(A) A11 and B12A TCRs do not display alloreactivity against allogeneic pMHC complexes. Anti-mCD155 (10 mg/ml) blocked responses of TCR-transduced 4G4
cells (43 104) to a panel of allogeneic stimulator cells (53 105), but did not block alloreactive responses of primary B6 T cells. IL-2 responses of primary B6 T cells
(23 105) in the presence of anti-mCD155were expressed relative to those in the absence of anti-mCD155, which were set equal to 100%. Actual amounts of IL-2
secreted in response to each stimulator strain were BALB/c = 292 pg/ml; A/J = 277 pg/ml; CBA = 1,234 pg/ml. Each data point represents the mean (±SEM) of
triplicate culture. Data are representative of three experiments.
(B) Binding of soluble B12A TCR to recombinant mCD155 protein. Surface plasmon resonance (SPR) measurements of binding between solubilized B12A abTCR
heterodimers and immobilized recombinant mCD155. The analytes consisted of serial dilutions of soluble abTCR heterodimers ranging from 0.11 to 1.76 mM. The
dissociation constants were obtained by kinetic curve fitting via BIAevaluation. Data are representative of two experiments.
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MHC complexes that either syngeneic or allogeneic stimulator
cells expressed (Figure 7A).
High-Affinity Binding of Soluble B12A TCRs to
Recombinant mCD155
Finally, we generated soluble B12A a and b extracellular
domains that refolded together to form soluble B12A ab hetero-
dimers whose binding to recombinant mCD155 protein could be
determined by surface plasmon resonance (Figure 7B). In an
entirely cell-free assay containing only B12A TCRs and recombi-
nant mCD155 protein, we observed that soluble B12A TCRs did
directly bind to recombinant mCD155 proteins and did so
with the surprisingly high affinity of 200 nM (Figure 7B). The
observed binding affinity is substantially higher than the
10–200 mM affinities with which conventional abTCRs bind to
peptide-MHC ligands (Margulies, 1997; Matsui et al., 1991).Indeed, the high binding affinity of B12A TCRs to mCD155 was
consistent with our observations that B12A TCRs on intact cells
(4G4 and hPBL) signaled mCD155-specific responses without
contributions from CD4 or CD8 coreceptor proteins or from
species-specific adhesion molecules. These results indicate
that mCD155 is the primary ligand for B12A abTCRs and per-
haps for A11 abTCRs as well, although we have not yet success-
fully obtained soluble A11 ab heterodimers.
DISCUSSION
The present study reveals that MHC restriction is extrinsically
imposed on the developing abTCR repertoire. We have shown
that T cells unscreened for MHC specificity in the thymus can
express abTCRs that recognize conformational antigenic epi-
topes independently of MHC molecules. The two abTCRs
analyzed in detail here (A11 and B12A) recognized differentImmunity 36, 79–91, January 27, 2012 ª2012 Elsevier Inc. 87
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abTCRs with Unique Ligand Specificitiesepitopes on CD155, a self-protein whose structure does not
resemble that of MHC molecules (He et al., 2000; Rudolph
et al., 2006; Takai et al., 2003; Zhang et al., 1992). Importantly,
TCR recognition of CD155 was dependent on glycosylation
and involved CDR3-encoded amino acids in the TCR antigen
combining site, demonstrating that abTCR recognized CD155
as a ‘‘conventional’’ antigen and not as a superantigen. In addi-
tion, MHC-independent TCR recognition of CD155 involved
CDR2-encoded amino acids that were the identical CDR2-
encoded residues required for recognition of pMHC complexes
by conventional abTCRs (Scott-Browne et al., 2009). We con-
clude that MHC specificity is not intrinsic to the germline-
encoded structure of all abTCRs and that, in the absence of
MHC-specific thymic selection, ligand recognition by abTCRs
can resemble that of antibodies.
The present study was based on the concept that thymic
selection was constrained by CD4 and CD8 coreceptors to be
specific for MHC molecules, so that in Quad-deficient mice,
thymic selection would be MHC independent and result in
mature T cells expressing abTCRs with novel ligand recognition
specificities (schematized in Figure S4). A11 and B12A TCRs
were obtained from T hybridoma cells made from peripheral ab
T cells generated in Quad-deficient.Bcl2 mice. The particular
ab T cell from which the B12 T hybridoma was constructed con-
tained one TCRb chain but two different, yet closely related, TCR
Va4 chains: one TCR Va4 chain that formed the B12F TCR and
was probably a passenger TCR chain during thymic selection,
and one TCR Va4 chain that formed the B12A TCR and probably
promoted thymic selection. The Va4Vb3 B12F TCR, which had
no discernible ligand recognition specificity, provided an excel-
lent negative TCR control for our present studies because it
was nearly identical to the Va4Vb3 B12A TCR and primarily
differed in Ja-encoded CDR3a sequences. Unlike the pMHC
ligands recognized by conventional abTCRs, A11 and B12A
TCRs recognized glycosylation-dependent conformational epi-
topes on native CD155 proteins that required neither antigen
processing nor antigen-presenting cells. As a result, antibodies
specific for conformational epitopes on mCD155 blocked ligand
recognition by A11 and B12A TCRs, whereas ligand recogni-
tion by conventional abTCRs was blocked only by antibodies
directed against MHC molecules. Moreover, the ability of
plate-bound recombinant mCD155 to trigger A11 and B12A
TCRs to signal both murine 4G4 cells and human PBL in the
absence of any antigen-presenting cells indicated that A11 and
B12A boundmCD155 with sufficient affinity to trigger TCR signal
transduction without contribution from intercellular adhesion
molecules. Moreover, we were able to generate solubilized
B12A abTCR heterodimers and to determine that they bound
recombinant mCD155 protein with 200 nM affinity, which
was 10–100 times higher than the micromolar affinities with
which conventional abTCRs bind antigenic pMHC complexes
(Manning and Kranz, 1999; Margulies, 1997).
A few abTCRs capable of MHC-independent ligand binding
have been previously reported but, in contrast to the TCRs in
the present study, all such abTCRs were obtained from T cells
that had undergone MHC-specific thymic selection and dis-
played low apparent affinity for their MHC-independent ligand
(Barnd et al., 1989; Hanada et al., 2011; Rao et al., 1984). As
the most recent example, an abTCR obtained from T cells in88 Immunity 36, 79–91, January 27, 2012 ª2012 Elsevier Inc.human PBL bound a self-ligand independently of MHC, but it
did so with low apparent affinity because it was unable to bind
its MHC-independent ligand without additional CD2-CD58
adhesive interactions (Hanada et al., 2011). It has been argued
that such low-affinity binding to MHC-independent ligands can
be a property of MHC-specific abTCRs because they would
bind only MHC-independent ligands when their preferred
pMHC ligands were unavailable (Garcia et al., 2009). However,
this argument is directly contradicted by the abTCRs in the
present study, which bind mCD155 with high affinity. Moreover,
A11 and B12A TCRs recognized their MHC-independent ligand
even when confronted by a vast array of potential pMHC com-
plexes on a panel of syngeneic and allogeneic stimulator cells,
indicating that these MHC-independent abTCRs were not allor-
eactive and that CD155 was probably their primary ligand.
In fact, the absence of A11 and B12A cross-reactivity contrasts
with the extensive cross-reactivity displayed by conventional
abTCRs, suggesting that extensive cross-reactivity derives
from MHC-specific thymic selection.
Analysis of CD155 recognition by MHC-independent TCRs
revealed that it was mediated by the TCR antigen combining
site and not by another site on the TCR. Experiments involving
reciprocal exchanges of CDR3a sequences between B12A and
B12F TCRs documented that B12A CDR3a sequences induced
CD155 recognition by B12F TCR and that B12F CDR3a se-
quences abrogated CD155 recognition by B12A TCR. The fact
that MHC-independent recognition of CD155 is mediated by
the TCR antigen-combining site proves that CD155 is specifi-
cally recognized as an antigen, albeit an MHC-independent
antigen, but is not recognized nonspecifically as either a super-
antigen or an adhesion molecule.
Further analysis of CD155 recognition by A11 TCR revealed
that it involved the same evolutionarily conserved CDR2b-
encoded amino acid residues (Y46, Y48, E54) that, in conven-
tional Vb8 TCRs, contact MHC and are thought to confer
MHC specificity (Scott-Browne et al., 2009; Yin et al., 2011).
Indeed, these CDR2b-encoded residues were required for
thymic selection of at least one MHC-restricted transgenic
TCR (Scott-Browne et al., 2009). However, the proposal that
these germline-encoded CDR2b amino acid residues imposed
MHC specificity was tested only on MHC-selected TCRs. The
present study now documents that the identical CDR2b residues
that promote TCR recognition of pMHC ligands (Garcia et al.,
2009; Scott-Browne et al., 2009; Yin et al., 2011) also promote
TCR recognition of theMHC-independent ligand CD155. In other
words, this study indicates that germline-encoded CDR2b resi-
dues promote ligand recognition by abTCRs regardless of
whether the ligand is MHC dependent or MHC independent.
Consequently, we think that these germline-encoded MHC
contact residues neither impose MHC specificity nor prevent
abTCR from binding MHC-independent ligands.
Nevertheless, we do think that evolutionary pressures have
created a germline bias toward MHC recognition, but the bias
is not strong enough to have eliminated MHC-independent
abTCRs. Indeed, the current study supports a potential mecha-
nism bywhich evolutionary pressures create such a bias. Specif-
ically, we think that the evolutionary pressure for germline bias
toward MHC recognition is exerted during thymic selection
because Lck in immature thymocytes is sequestered away
Immunity
abTCRs with Unique Ligand Specificitiesfrom the TCR by CD4 and CD8 coreceptor proteins (Van Lae-
them et al., 2007). It is our perspective that the dual specificity
of CD4 and CD8 coreceptors for extracellular MHC and intracel-
lular Lck provides the molecular basis for thymic selection of
MHC-specific T cells and provides the evolutionary pressure
for a germline bias toward recognition of MHC molecules (Van
Laethem et al., 2007).
Murine CD155 is the murine analog of the human polio virus
receptor and is a member of the nectin-like family of adhesion
molecules. CD155 is bound by a number of counter-receptors
(Miyoshi and Takai, 2007) that could theoretically either promote
or impair TCR binding to CD155. Indeed, it is conceivable
that CD155 counter-receptors might be able to contribute to
CD155-specific abTCRs in a manner analogous to CD4 and
CD8 coreceptors, which contribute to the pMHC specificity of
conventional abTCRs. Notably, B12A TCR recognition of CD155
was not dependent on CD155 counter-receptors because, in a
cell-free assay devoid of all other proteins, soluble B12A TCRs
directly bound to recombinant murine CD155 protein with high
affinity. In addition, when expressed on human PBL bearing
human counter-receptors that bind strongly to human but not
murine CD155, A11 and B12A TCRs nevertheless signaled
hPBL to respond to plate-bound murine CD155 proteins.
It was surprising that two different abTCRs recognized the
same self-protein, albeit different epitopes on that protein,
raising the possibility that CD155 might be a unique ligand for
MHC-independent TCRs, perhaps analogous to MHC for con-
ventional abTCRs. While intriguing, such a possibility is contra-
dicted by the fact that polyclonal ab T cells from Quad-deficient
mice reacted against CD155-deficient stimulators, indicating
that polyclonal ab T cells recognized additional MHC-indepen-
dent ligands other than CD155. Instead, we think that the
apparent overrepresentation of MHC-independent abTCRs
from Quad-deficient mice with specificity for CD155 may have
resulted from fusing Quad-deficient ab T cells with BW5147 cells
to construct T hybridoma cell lines. The fusion of ab T cells with
BW5147 extinguishes expression of a number of genes, such as
Cd8 (Lee et al., 1994), and Cd155 may also be one of those
genes because CD155 expression was markedly reduced on
T hybridoma cells. Because its expression is reduced on
T hybridomas, T hybridomas with abTCR specific for CD155
would expand because they would not be constitutively sig-
naled, whereas T hybridoma cells with abTCR specific for
MHC-independent ligands that T hybridoma cells express would
be continuously stimulated and signaled to commit fratricide. As
a result, MHC-independent abTCRs derived from T hybridoma
cells would give the appearance of being markedly skewed
toward CD155 specificity. Experiments to generate MHC-
independent abTCRs fromQuad-deficient micewith other ligand
specificities are in progress.
In conclusion, this study demonstrates that, in the absence of
MHC-specific thymic selection, T cells can resemble B cells in
their expression of antigen-specific receptors that recognize
glycosylation-dependent conformational epitopes on unpro-
cessed protein antigens independently of MHC molecules.
This study contradicts the perspective that MHC specificity is
intrinsic to the structure of all abTCRs and suggests the exis-
tence of a repertoire of abTCRs with specificity for MHC-
independent ligands that has never been examined. Thus, thisstudy indicates that abTCRs need to be screened for MHC
specificity in the thymus in order to insure the generation of an
MHC-restricted peripheral abTCR repertoire.
EXPERIMENTAL PROCEDURES
Animals
C57BL/6 (B6), BALB/c, and B10.A mice were obtained from NCI Fred-
erick (Frederick, MD). MHC-deficient (B2m/H-2-Ab1/), Quad-deficient
(B2m/H-2-Ab1/Cd4/Cd8a/) (Van Laethem et al., 2007), and Quad-
deficient.Bcl2 mice containing the hBcl2 transgene (Linette et al., 1996) were
bred in our own animal colony. Mice deficient in CD155 (Cd155/) were
generated as described (Maier et al., 2007). Animal care was in accordance
with National Institutes of Health (NIH) guidelines.
Generation of T Cell Hybridomas
ab lymph node T (LNT) cells from Quad-deficient.Bcl-2 mice were stimulated
with plate-bound anti-TCRb/CD28 (10 mg/ml) for 48 hr, fused to TCR-null
BW5147cells, andsubclonedat<1cell/well (VanLaethemetal., 2007). Thybrid-
omas reactive against MHC-deficient stimulator cells were selected for further
study. IL-2 secretion was measured by the IL-2-dependent CTLL-2 cell line
with the Alamar Blue colorimetric assay (Ahmed et al., 1994). The TCR-deficient
4G4cell line (Honget al., 1992)waskindlyprovidedbyA.Chervonsky (University
of Chicago).
Reagents
MAbs with the following specificities were used: murine TCRb (clone H57-957;
Becton Dickinson, San Diego, CA) andmurine CD155 (clones TX56 and 4.42.1;
Biolegend, San Diego, CA). Glycosylated recombinant human and mouse
CD155 were purchased from Sino Biologicals (Beijing, China). Nonglycosy-
lated recombinant CD155 protein was made in bacteria. Polyclonal rabbit
anti-CD155 was purchased from Sino Biologicals. LEAF-purified antibody
(4.24.1) against mouse CD155 was obtained from Biolegend. Murine IL-2
was measured either with the CTLL-2 bioassay or by enzyme-linked immuno-
sorbent assays (ELISA) (R&D Systems, Minneapolis, MN). Human IFN-g was
measured by ELISA (R&D Systems). Mouse CD155 cDNA cloned into
pCMV6Entry vector was obtained from OriGene (Rockville, MD).
abTCR Constructs and Retroviral Transductions
Full-length TCR cDNAs for TCRa and TCRb were cloned with PCR primers
specific to sequences 50 of the start and 30 of the stop of rearranged TCR
chains. TCR expression constructs were cloned in murine stem cell virus
(MSCV)-based retroviral plasmids and transfected into PlatE cells to produce
retrovirus containing supernatants. TCRb was cloned into pMX-IRES-GFP
(provided by R. Bosselut, NCI) and TCRa was cloned into MSV-IRES-tNGFR
(provided by W. Pear, University of Pennsylvania). TCRs were expressed by
retroviral transduction in TCR-deficient 4G4 cells with 2 mg/ml of polybrene.
For stimulation assays, 4 3 104 retrovirally transduced 4G4 cells were incu-
bated with stimulators for 16 hr at 37C, 5% CO2.
TCR transduction to human PBL was done as described (Frankel et al.,
2010). In brief, retrovirus was prepared by cotransfecting the 293 gp retrovirus
producer cell line with retrovirus vectors that encode TCR genes and the
RD-114 envelope plasmid. hPBLs were stimulated with anti-CD3 (OKT3) at
50 ng/ml in AIM-V with human IL-2 (300 IU/ml) for 2 days prior to retroviral
transduction. Retroviral supernatant was spin-loaded onto RetroNectin
(Takara Bio, Otsu, Japan)-coated plates (10 mg/ml in PBS, overnight) by centri-
fugation at 2,000 3 g for 2 hr at 32C. hPBLs were then loaded onto plates,
centrifuged at 1,000 3 g for 10 min, and incubated overnight at 37C,
5% CO2, and retrovirally transduced a second time with the second set of
plates loaded with retrovirus. During stimulation assays, 2 3 105 retrovirally
transduced hPBL were incubated with stimulators at 37C, 5% CO2.
Construction and Screening of the cDNA Library
Total RNA was obtained from the murine L1210 cell line by RNeasy Maxi
(QIAGEN Inc., Valencia, CA) and was purified with FastTrack MAG Maxi
mRNA isolation kit (Invitrogen, Carlsbad, CA) to obtain poly(A)+ RNA. cDNA
was synthesized with the SuperScript system (Invitrogen) and was clonedImmunity 36, 79–91, January 27, 2012 ª2012 Elsevier Inc. 89
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abTCRs with Unique Ligand Specificitiesinto SPORT6 vector with SalI and NotI restriction sites. ElectroMAX DH10B
competent cells (Invitrogen) were transformed by electroporation, and after
titration, E. coli (150 clones/well) were inoculated overnight into 96-well
format culture blocks (10 blocks). Plasmids were purified with a Qiaprep 96
Turbo miniprep kit (QIAGEN) and were transfected to HEK293T cells with Lip-
ofectamine 2000 (Invitrogen) in 96-well flat-bottom plates and left overnight.
Transduced 4G4 cells were coculturedwith cDNA-transfected 293T cells for
24 hr, after which mIL-2 amounts in the supernatants were determined. Posi-
tive clones were selected for secondary and tertiary screenings. Subpool
libraries (20 clones/well, 48 wells) and clone libraries (1 clone/well, 96 wells)
were prepared and screened. Positive clones were sequenced to identify the
specificity of the transfected cDNA.Stimulation with Plate-Bound Ligands
Flat-bottom 96-well plates were coated overnight with intact or heat-
denatured recombinant hCD155 or mCD155 in 50 ml of PBS. Transduced
4G4 cells (4 3 104 cells) or hPBLs (2 3 105 cells) were added overnight, after
which supernatants were assessed for IL-2 or hIFN-g.Generation of Soluble abTCR Heterodimers
DNA encoding extracellular portions of TCR a and b chains were cloned into
pET30a vectors (GenScript, Piscataway, NJ) (Dai et al., 2008; Tynan et al.,
2007). Receptors were expressed as inclusion bodies in BL21 (DE3) cells.
Functional and soluble TCR heterodimers were produced by a rapid dilution
refolding procedure as previously described (Clements et al., 2002).Surface Plasmon Resonance
Surface plasmon resonance (SPR) measurements were performed with a
BIAcore 3000 instrument and analyzed with BIAeveluation 4.1 software
(GE Healthcare, Piscataway, NJ). To measure the affinity of the TCRs,
CD155 was immobilized on caboxylated dextran CM5 chips (GE Healthcare)
to 200–500 response units (RU) with a primary amine-coupling and 5 ml/min
flow rate in 10 mM sodium acetate (pH 5.5). The analytes consisted of serial
dilutions of soluble TCR heterodimers from 0.31 to 2.5 mM in a buffer contain-
ing 10 mM HEPES (pH 7.4) and 0.15 M NaCl. The dissociation constants were
obtained by kinetic curve fitting with BIAevaluation (GE Healthcare).Epitope Mapping
Chimeric CD155 molecules between human and mouse were constructed.
The chimeric constructs were synthesized (GenScript) and cloned into
pIRES2-ZsGreen1 expression vector. Transduced 4G4 cells (4 3 104 cells)
were cocultured with 293T cells transfected with chimeric cDNA for 24 hr, after
which supernatant IL-2 was measured.Exchange of CDR3a-Encoded TCR Sequences
B12A TCRa containing B12F TCRa CDR3 region (A-CDR3-F) and B12F
TCRa containing B12A TCRa CDR3 region (F-CDR3-A) were constructed.
The CDR3a TCR mix-and-match constructs were synthesized (GenScript)
and cloned into MSV-IRES-tNGFR. B12 TCRb was cloned into pMX-IRES-
GFP. TCRs were expressed by retroviral transduction in TCR-deficient 4G4
cells. For stimulation assays, 1 3 105 transduced 4G4 cells were stimulated
overnight with plate-bound mCD155 (5 mg/ml) or anti-TCRb (5 mg/ml) in flat-
bottom 96-well plate for 16 hr at 37C, 5% CO2.TCR Mutagenesis
Constructs containing A11 TCRVb with Y46A, Y48A, or E54A mutations in
CDR2 region were synthesized (GenScript) and cloned into pMX-IRES-GFP.
A11 TCRa was cloned into MSV-IRES-tNGFR. TCRs were expressed by
retroviral transduction in TCR-deficient 4G4 cells.SUPPLEMENTAL INFORMATION
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